Allogeneic graft-versus-tumor effects: Mechanistic insights and therapeutic promise

  • Fowler D
  • Gress R
  • 1


    Mendeley users who have this article in their library.
  • 0


    Citations of this article.


Cellular and molecular mechanisms of allogeneic graft-versus-tumor (GVT) effects include Th1 and Tc1 cell interleukin-2 (IL-2) and interferon-γ (IFN-γ) secretion, antigen-presenting cell (APC) IL-1-α and tumor necrosis factor-α (TNF-α) secretion, and cytolytic effectors operating through perforin, fas and TNF-related apoptosis inducing ligand (TRAIL) pathways. Because such mechanisms also contribute to graft-versus-host disease (GVHD), separation of GVT effects from GVHD has proven problematic. Research advances in allograft T cell engineering and cytokine, vaccine and molecularly targeted therapy hold promise for improved harnessing of GVT effects. © 2005 Elsevier Ltd. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Daniel H. Fowler

  • Ronald E. Gress

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free